These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 19751331

  • 21. Triage of women with ASCUS and LSIL on Pap smear reports: management by repeat Pap smear, HPV DNA testing, or colposcopy?
    Ferris DG, Wright TC, Litaker MS, Richart RM, Lorincz AT, Sun XW, Borgatta L, Buck H, Kramer L, Rubin R.
    J Fam Pract; 1998 Feb; 46(2):125-34. PubMed ID: 9487318
    [Abstract] [Full Text] [Related]

  • 22. Post-treatment human papillomavirus status and recurrence rates in patients treated with loop electrosurgical excision procedure conization for cervical intraepithelial neoplasia.
    Du R, Meng W, Chen ZF, Zhang Y, Chen SY, Ding Y.
    Eur J Gynaecol Oncol; 2013 Feb; 34(6):548-51. PubMed ID: 24601049
    [Abstract] [Full Text] [Related]

  • 23. [Combining high-risk human papillomavirus DNA test and cytological test to detect early cervical dysplasia].
    Qian DY, Cen JM, Wang D, Zeng RH, Lin AH, Shu YH, Hong DH, Huang ZH.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):34-7. PubMed ID: 16635326
    [Abstract] [Full Text] [Related]

  • 24. Human papillomavirus genotyping as a reliable prognostic marker of recurrence after loop electrosurgical excision procedure for high-grade cervical intraepithelial neoplasia (CIN2-3) especially in postmenopausal women.
    Kang WD, Kim SM.
    Menopause; 2016 Jan; 23(1):81-6. PubMed ID: 26057824
    [Abstract] [Full Text] [Related]

  • 25. Assessment of cervical intraepithelial neoplasia (CIN) with colposcopic biopsy and efficacy of loop electrosurgical excision procedure (LEEP).
    Duesing N, Schwarz J, Choschzick M, Jaenicke F, Gieseking F, Issa R, Mahner S, Woelber L.
    Arch Gynecol Obstet; 2012 Dec; 286(6):1549-54. PubMed ID: 22865036
    [Abstract] [Full Text] [Related]

  • 26. The clinical value of digene hybrid capture HPV DNA testing in a referral-based population with abnormal pap smears.
    Recio FO, Sahai Srivastava BI, Wong C, Hempling RE, Eltabbakh GH, Piver MS.
    Eur J Gynaecol Oncol; 1998 Dec; 19(3):203-8. PubMed ID: 9641214
    [Abstract] [Full Text] [Related]

  • 27. Contribution of human papillomavirus testing by hybrid capture in the triage of women with repeated abnormal pap smears before colposcopy referral.
    Fait G, Kupferminc MJ, Daniel Y, Geva E, Ron IG, Lessing JB, Bar-Am A.
    Gynecol Oncol; 2000 Nov; 79(2):177-80. PubMed ID: 11063640
    [Abstract] [Full Text] [Related]

  • 28. High-risk HPV DNA detection by Hybrid Capture II. An adjunctive test for mildly abnormal cytologic smears in women > or = 50 years of age.
    Lin CT, Tseng CJ, Lai CH, Hsueh S, Huang HJ, Law KS.
    J Reprod Med; 2000 Apr; 45(4):345-50. PubMed ID: 10804494
    [Abstract] [Full Text] [Related]

  • 29. Value of human papillomavirus testing after conization by loop electrosurgical excision for high-grade squamous intraepithelial lesions.
    Houfflin Debarge V, Collinet P, Vinatier D, Ego A, Dewilde A, Boman F, Leroy JL.
    Gynecol Oncol; 2003 Sep; 90(3):587-92. PubMed ID: 13678729
    [Abstract] [Full Text] [Related]

  • 30. Linear array genotyping and hybrid capture II assay in detecting human papillomavirus genotypes in women referred for colposcopy due to abnormal Papanicolaou smear.
    Monsonego J, Pollini G, Evrard MJ, Sednaoui P, Monfort L, Quinzat D, Dachez R, Syrjänen K.
    Int J STD AIDS; 2008 Jun; 19(6):385-92. PubMed ID: 18595876
    [Abstract] [Full Text] [Related]

  • 31. A comparison of the human papillomavirus test and Papanicolaou smear as a second screening method for women with minor cytological abnormalities.
    Andersson S, Dillner L, Elfgren K, Mints M, Persson M, Rylander E.
    Acta Obstet Gynecol Scand; 2005 Oct; 84(10):996-1000. PubMed ID: 16167918
    [Abstract] [Full Text] [Related]

  • 32. Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries?
    Bhatla N, Dar L, Patro AR, Kumar P, Kriplani A, Gulati A, Iyer VK, Mathur SR, Sreenivas V, Shah KV, Gravitt PE.
    Cancer Epidemiol; 2009 Dec; 33(6):446-50. PubMed ID: 19931499
    [Abstract] [Full Text] [Related]

  • 33. Human papillomavirus testing as triage for atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions: sensitivity, specificity, and cost-effectiveness.
    Kaufman RH, Adam E, Icenogle J, Reeves WC.
    Am J Obstet Gynecol; 1997 Oct; 177(4):930-6. PubMed ID: 9369847
    [Abstract] [Full Text] [Related]

  • 34. High-risk HPV testing in women with borderline and mild dyskaryosis: long-term follow-up data and clinical relevance.
    Denise Zielinski G, Snijders PJ, Rozendaal L, Voorhorst FJ, Runsink AP, de Schipper FA, Meijer CJ.
    J Pathol; 2001 Oct; 195(3):300-6. PubMed ID: 11673826
    [Abstract] [Full Text] [Related]

  • 35. Human papillomavirus (HPV) testing in the management of women with abnormal Pap smears. Experience of a colposcopy referral clinic.
    Ciotti M, Sesti F, Paba P, Benedetto A, Patrizi L, Criscuolo A, Piccione E, Branca M, Syrjänen K, Favalli C.
    Eur J Gynaecol Oncol; 2004 Oct; 25(5):577-84. PubMed ID: 15493169
    [Abstract] [Full Text] [Related]

  • 36. The significance of HPV in the follow-up period after treatment for CIN.
    Gallwas J, Ditsch N, Hillemanns P, Friese K, Thaler C, Dannecker C.
    Eur J Gynaecol Oncol; 2010 Oct; 31(1):27-30. PubMed ID: 20349777
    [Abstract] [Full Text] [Related]

  • 37. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.
    Manos MM, Kinney WK, Hurley LB, Sherman ME, Shieh-Ngai J, Kurman RJ, Ransley JE, Fetterman BJ, Hartinger JS, McIntosh KM, Pawlick GF, Hiatt RA.
    JAMA; 1999 May 05; 281(17):1605-10. PubMed ID: 10235153
    [Abstract] [Full Text] [Related]

  • 38. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance.
    ASCUS-LSIL Traige Study (ALTS) Group.
    Am J Obstet Gynecol; 2003 Jun 05; 188(6):1383-92. PubMed ID: 12824967
    [Abstract] [Full Text] [Related]

  • 39. Persistence of human papillomavirus as a predictor for treatment failure after loop electrosurgical excision procedure.
    Bae JH, Kim CJ, Park TC, Namkoong SE, Park JS.
    Int J Gynecol Cancer; 2007 Jun 05; 17(6):1271-7. PubMed ID: 17442018
    [Abstract] [Full Text] [Related]

  • 40. Human papillomavirus testing in primary screening for cervical cancer of human immunodeficiency virus-infected women, 1990-1998.
    Petry KU, Böhmer G, Iftner T, Flemming P, Stoll M, Schmidt RE.
    Gynecol Oncol; 1999 Dec 05; 75(3):427-31. PubMed ID: 10600301
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.